Wendy A. Davis

10.2k total citations
249 papers, 7.2k citations indexed

About

Wendy A. Davis is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Wendy A. Davis has authored 249 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Endocrinology, Diabetes and Metabolism, 50 papers in Surgery and 49 papers in Epidemiology. Recurrent topics in Wendy A. Davis's work include Diabetes Treatment and Management (44 papers), Diabetes Management and Research (40 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (39 papers). Wendy A. Davis is often cited by papers focused on Diabetes Treatment and Management (44 papers), Diabetes Management and Research (40 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (39 papers). Wendy A. Davis collaborates with scholars based in Australia, United States and United Kingdom. Wendy A. Davis's co-authors include Timothy M. E. Davis, David Bruce, S. A. Paul Chubb, Sergio Starkstein, Matthew Knuiman, Paul E. Norman, Kirsten E. Peters, Rhonda Clifford, Marilyn Jacobs Quadrel and Baruch Fischhoff and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Wendy A. Davis

244 papers receiving 6.9k citations

Peers

Countries citing papers authored by Wendy A. Davis

Since Specialization

Citations

This map shows the geographic impact of Wendy A. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy A. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy A. Davis more than expected).

Fields of papers citing papers by Wendy A. Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy A. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy A. Davis. The network helps show where Wendy A. Davis may publish in the future.

Co-authorship network of co-authors of Wendy A. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy A. Davis. A scholar is included among the top collaborators of Wendy A. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy A. Davis. Wendy A. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Accelerating diabetes innovation for real‐world community impact through interdisciplinary research: Who is at the table? 2025 ·Diabetic Medicine ·Elizabeth Holmes‐Truscott, Joanne M. Jordan, Leonid Churilov, Wendy A. Davis, Sarah J. Glastras, Marlena Klaic, (unknown), An Tran‐Duy, David N. O’Neal, Elif I. Ekinci	0
2	PromarkerD Versus Standard of Care Biochemical Measures for Assessing Future Renal Function Decline in Type 2 Diabetes 2025 ·Diagnostics ·Kirsten E. Peters, Ilse Joubert, Scott Bringans, Wendy A. Davis, Richard Lipscombe, Timothy M. E. Davis	1
3	Application of a validated prognostic plasma protein biomarker test for renal decline in type 2 diabetes to type 1 diabetes: the Fremantle Diabetes Study Phase II 2024 ·SHILAP Revista de lepidopterología ·Timothy M. E. Davis, Wendy A. Davis, Scott Bringans, (unknown), (unknown), Kirsten E. Peters, Richard Lipscombe	1
4	The inter-relationship between Helicobacter pylori infection, dementia and mortality in type 2 diabetes: The Fremantle Diabetes Study Phase I 2024 ·Journal of Diabetes and its Complications ·Timothy M. E. Davis, David Bruce, (unknown), S. A. Paul Chubb, Wendy A. Davis	1
5	Use of a type 1 genetic risk score for classification of diabetes type in young Australian adults: the Fremantle Diabetes Study Phase II 2024 ·Internal Medicine Journal ·Timothy M. E. Davis, Kirsten E. Peters, Wendy A. Davis	3
6	Comparative mortality and its determinants in community-based people with type 1 diabetes: the Fremantle Diabetes Study Phase I 2023 ·BMJ Open Diabetes Research & Care ·(unknown), Wendy A. Davis, Timothy M. E. Davis	2
7	Group-Based Trajectory Modelling of Changes in Mobility over Six Years in Type 2 Diabetes: The Fremantle Diabetes Study Phase II 2023 ·Journal of Clinical Medicine ·David Bruce, Wendy A. Davis, Timothy M. E. Davis	0
8	Temporal trends in minor and major lower extremity amputation in people with type 2 diabetes: The Fremantle Diabetes Study 2023 ·Diabetes and Vascular Disease Research ·Emma Hamilton, Wendy A. Davis, (unknown), Timothy M. E. Davis	2
9	Glycaemic control and mortality in older people with type 2 diabetes: The Fremantle Diabetes Study Phase II 2018 ·Diabetes Obesity and Metabolism ·David Bruce, Wendy A. Davis, Timothy M. E. Davis	19
10	Clinical risk factors for depressive syndrome in Type 2 diabetes: the Fremantle Diabetes Study 2018 ·Diabetic Medicine ·David Bruce, Wendy A. Davis, Sergio Starkstein, Timothy M. E. Davis	5
11	Depression symptoms are persistent in Type 2 diabetes: risk factors and outcomes of 5‐year depression trajectories using latent class growth analysis 2017 ·Diabetic Medicine ·(unknown), David Bruce, Sergio Starkstein, Wendy A. Davis, Timothy M. E. Davis, Timothy Skinner, Romola S. Bucks	23
12	Influence of Premature Mortality on the Link Between Type 2 Diabetes and Hip Fracture: The Fremantle Diabetes Study 2016 ·The Journal of Clinical Endocrinology & Metabolism ·Emma Hamilton, Wendy A. Davis, David Bruce, Timothy M. E. Davis	10
13	Prevalence of depression and its associations with cardio-metabolic control in Aboriginal and Anglo-Celt patients with type 2 diabetes: The Fremantle Diabetes Study Phase II 2015 ·Diabetes Research and Clinical Practice ·Timothy M. E. Davis, (unknown), David Bruce, Sergio Starkstein, Timothy Skinner, Daniel McAullay, Wendy A. Davis	18
14	Self‐awareness of foot health status in patients with Type 2 diabetes: the Fremantle Diabetes Study Phase II 2014 ·Diabetic Medicine ·Masayuki Baba, (unknown), Wendy A. Davis, Timothy M. E. Davis	14
15	Significance of and Risk Factors for the Development of Central Airway Stenosis After Lung Transplantation 2012 ·American Journal of Transplantation ·Scott Shofer, Momen M. Wahidi, Wendy A. Davis, Scott M. Palmer, Matthew G. Hartwig, Yibing Lu, Laurie D. Snyder	33
16	An Australian cardiovascular risk equation for type 2 diabetes: the Fremantle Diabetes Study 2009 ·Internal Medicine Journal ·Wendy A. Davis, Matthew Knuiman, Timothy M. E. Davis	67
17	Predictors of cognitive impairment and dementia in older people with diabetes 2007 ·Diabetologia ·David Bruce, Wendy A. Davis, (unknown), Sergio Starkstein, Roger Clarnette, Jonathan K. Foster, Osvaldo P. Almeida, Timothy M. E. Davis	113
18	Bone mineral density and its determinants in diabetes: the Fremantle Diabetes Study 2006 ·Diabetologia ·Valentina Rakic, Wendy A. Davis, S. A. Paul Chubb, Amirul Islam, Richard L. Prince, Timothy M. E. Davis	75
19	Prevalence and Predictors of Complementary Medicine Usage in Diabetes: Fremantle Diabetes Study 2003 ·Journal of Pharmacy Practice and Research ·Rhonda Clifford, Kevin T. Batty, Wendy A. Davis, Timothy M. E. Davis	27
20	General practice orthopaedic outpatient referrals in North Staffordshire. 1983 ·BMJ ·(unknown), Wendy A. Davis, G. Horn, Ruth Williams	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact